English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3057]
News [6190]
Articles [123]
Editorials [18]
Conferences [183]
elearning [32]
Cracking carboplatin resistance: Forward genetics identifies Hn1l/Jpt2 as a novel player in ovarian cancer’s escape from platinum therapy
Cracking carboplatin resistance: Forward genetics identifies Hn1l/Jpt2 as a novel player in ovarian cancer’s...
Researchers uncover surprising role of 'natural killer' cells in resistance to cancer immunotherapy
Researchers uncover surprising role of 'natural killer' cells in resistance to cancer immunotherapy
A technology that detects breast cancer relapses up to 5 years in advance has been developed
A technology that detects breast cancer relapses up to 5 years in advance has been developed
Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications
Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications
Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer
Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel...
The role of inflammatory mediators in age-related and postmenopausal breast cancer
The role of inflammatory mediators in age-related and postmenopausal breast cancer
Gene mutation could be target for ‘ultrapersonalised’ therapies in colon cancer
Gene mutation could be target for ‘ultrapersonalised’ therapies in colon cancer
Scientists uncover clues behind drug resistance in bowel cancer
Scientists uncover clues behind drug resistance in bowel cancer
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the...
Thousands of blood cancer patients could benefit from new drug combination
Thousands of blood cancer patients could benefit from new drug combination
<1234567...619>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top